HRD Test For Ovarian Cancer

Ovarian Cancer tests helps your doctor determine if you are eligible for PARP inhibitors

Optimise your ovarian cancer treatment 

Myriad Genetics

Test performed by world renowned lab Myriad Genetics (USA). Positive Bioscience is the exclusive partner of Myriad in India.

US FDA Approved

First and ONLY US FDA approved comprehensive companion diagnostics HRD test for ovarian cancer.

Germline and Somatic Variants

Identifies both germline and somatic BRCA variants in the tumor.

GIS (HRD) Score

Only test available in India that calculates genomic instability.

myChoiceCDx ovarian cancer test for parp inhibitors

myChoice CDx for PARP Inhibitors

Myriad Genetics is a leading molecular diagnostic company based in the USA. Available in India, learn if you can take PARP inhibitors to treat your Ovarian Cancer with companion diagnostic test myChoice CDx.

Positive Bioscience is the exclusive partner for Myriad Genetics and only authorised provider of myChoice Cdx in India.

Our brochure explains in detail the benefits of the HRD test for ovarian cancer as well as what is included.

A test to help get the right treatment, to the right patient with ovarian cancer, at the right time.

myChoiceCDx ovarian cancer test for parp inhibitors

Biomarkers for Homologous Recombination Deficiency (HRD)

myChoice HRD India Ovarian Cancer

HRD Cancer Test = myChoice CDx

Patients with ovarian cancer need a test to check for hereditary cancer and best treatment options.

This HRD test helps get the right treatment, to the right patient with ovarian cancer, at the right time. DNA damage in ovarian cancer includes BRCA mutated causes.

myChoiceCDx ovarian cancer test for parp inhibitors

Know if you are eligible for PARP Inhibitors

With over 20 years of experience, Myriad Genetics is a pioneer of cancer risk assessment. This is not a blood test. The HRD test for ovarian cancer will help you determine if your doctor can prescribe you PARP inhibitors. Talk to your doctor and improve your quality of life.